Mild Cognitive Impairment and Dementia
Posted: 10 Jan 2008
Abstract
Mild cognitive impairment (MCI) is a clinical syndrome thought to represent the transition between normal function and dementia. This review describes data that support the existence of such a transitional phase, outlines the heterogeneity of MCI and how that has influenced the evolving concept of MCI, and discusses the impact of heterogeneity on recent MCI clinical trials.
Keywords: Alzheimer's disease, MCI, biomarkers, APOE, clinical trials
Suggested Citation: Suggested Citation
Albert, Marilyn S. and Blacker, Deborah, Mild Cognitive Impairment and Dementia. Annual Review of Clinical Psychology, Vol. 2, April 2007, Available at SSRN: https://ssrn.com/abstract=1081452
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.